Peptides related to thyrotrophin-releasing hormone (TRH) in human prostate and semen

Abstract

The TRH-related peptide, pGlu-Glu-ProNH 2, which was first identified in rabbit prostate has recently been named fertilization-promoting peptide (FPP) because of its ability to enhance the in vitro fertilizing potential of mouse epididymal spermatozoa. This study set out to examine the nature of the TRH-related peptides in human prostate and semen but, first, the optimal conditions for collection of semen samples were investigated. FPP was degraded slowly (t 1 2 = 163 min, S.E. ± 5.13, n = 6) in seminal plasma which has allowed us to measure acurrately the concentrations of FPP, after extraction of the peptide in acidified acetone precisely 5 min after ejaculation. In this way, high levels of FPP (mean: 49.5 nmol/1) were detected in normal human semen, from young men, although other TRH-related peptides did not appear to be present. We have also examined the TRH-related peptides present in prostate samples from clinical patients both with and without evidence of benign prostatic hyperplasia (BPH), by ion-exchange chromatography followed by radioimmunoassay. Substantial concentrations of FPP were observed in normal (4.10 pmol/tissue, S.E. ± 1.46) and BPH prostate (6.27 pmol/g tissue, S.E. ± 1.65). In addition, a second, neutral TRH-immunoreactive peptide was always detected in BPH tissie (7.40 pmol/g tissue, S.E. ± 1.98) with only low levels generally present in normal prostate. The possibility that the presence of high levels of the neutral peptide in prostate may be used as an indicator of the onset of BPH deserves further scrutiny.